LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital,which commercializes technology and healthcare research fromCambridge University, has raised 75 million pounds ($98 million)from investors, including for the first time Woodford InvestmentManagement.
CIC, founded in 2013, has already invested 33 million poundsin 13 technology and healthcare innovations, such as a companybuilding robots to do keyhole surgery and a drug developer thattargets RNA-modifying enzymes to treat cancer.
The new capital has come from fund manger Neil Woodford'scompany, Winton Ventures and the Oman Investment Fund as well asexisting shareholders including Cambridge-based chip designerARM Holdings and IP Group, CIC said on Friday.
Chief Executive Victor Christou said CIC had madesignificant progress in commercializing science stemming fromCambridge University and other local institutions in theCambridge Cluster, which he said was "one of the richest seamsof scientific and technological innovation in the world".
CIC is following in the footsteps of Imperial InnovationsGroup and its investor IP Group, both of which providecapital and commercial expertise to help researcherscommercialize research from Britain's world class universities.
($1 = 0.7620 pounds) (Reporting by Paul Sandle; editing by Susan Thomas)
